Shanghai Kehua Bio-engineering Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Shanghai Kehua Bio-engineering Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Shanghai Kehua Bio-engineering Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Shanghai Kehua Bio-engineering Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Shanghai Kehua Bio-engineering Co Ltd (KHB) develops, manufactures and markets in vitro diagnostic (IVD) devices and related products. The company's major products include diagnostic reagents and instruments for biochemical diagnosis, immunodiagnostics, molecular diagnosis, and point-of-care testing. The company's product portfolio includes Polaris LAS, a renal management solution, and the ZY-260, ZY-400, ZY-1200, and Polaris c1000 automatic analyzers, Polaris V150 and i2400 analyzers, ST-360 and ST-960 microplate readers, and ST-36W and ST-96W washers. Its products are utilized in clinical diagnosis and treatment, blood screening, public health, food safety, and scientific research. The company has sales support facilities in major cities in China and markets products in China and other countries through distributors. KHB is headquartered in Shanghai, China.
Headquarters
China
Address
No.1189, Qinzhou North Road, Xuhui District, Shanghai, 200233
Website
www.skhb.com
Telephone
86 21 64950625
No of Employees
1,870
Industry
Medical Equipment
Ticker Symbol & Exchange
002022 (SHE)
Revenue (2024)
$228.5M
-6.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-14.3%
(2024 vs 2023)
Market Cap*
$372.7M
Net Profit Margin (2024)
XYZ
-22.4%
(2024 vs 2023)
* As of and is in US$
Shanghai Kehua Bio-engineering Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Clinical Chemistry: | KHB |
| KHB ZY-260 - Automatic Clinical Chemistry Analyzer | Polaris Series |
| KHB ZY-400 - Automatic Clinical Chemistry Analyzer | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Shanghai Kehua Bio-engineering Co Ltd | Thermo Fisher Scientific Inc | Shenzhen Mindray Bio-Medical Electronics Co Ltd | Edan Instruments Inc | Beijing Strong Biotechnologies Inc |
|---|---|---|---|---|---|
| Headquarters | China | United States of America | China | China | China |
| City | Shanghai | Waltham | Shenzhen | Shenzhen | Beijing |
| State/Province | Shanghai | Massachusetts | Guangdong | Guangdong | Beijing |
| No. of Employees | 1,870 | 125,000 | 21,288 | 2,475 | 998 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Li Ming | Chairman; President | Executive Board | 2024 | 50 |
| Zang Xianfeng | Chief Financial Officer | Senior Management | - | 51 |
| Ma Zhichao | Vice Chairman | Executive Board | - | 46 |
| Jin Hongying | Secretary; Vice President; Director | Executive Board | - | 54 |
| Liang Jiaming | Vice President; Director | Executive Board | 2024 | 44 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer